Fig. 2: Timeline showing how baseline and follow-up window are defined. | npj Digital Medicine

Fig. 2: Timeline showing how baseline and follow-up window are defined.

From: Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer’s disease

Fig. 2

Patients who used 3 months of 10 mg donepezil were included in the study, their first use of 10 mg or 23 mg donepezil after the 3-month were used as baseline. The follow-up window is from baseline to 180 days after drug initiation. Follow-up window for serious adverse events (SAEs) related to treating Alzheimer’s disease with donepezil.

Back to article page